Taking semaglutide once weekly may lower the chances of kidney disease, says study

FHS
May 28, 2024
10:12 am

The effects of semaglutide (administered once weekly) on the outcomes of kidney disease.

Imlunestrant offers new hope for ER-positive HER2-negative breast cancer

Imlunestrant, an investigational next-generation selective estrogen receptor degrader (SERD), improved progression-free survival in patients with endocrine therapy-pretreated, ER-positive, HER2-negative advanced breast cancer-;as monotherapy in patients

December 11, 2024

Tezepelumab by Amgen for Chronic Obstructive Pulmonary Disease (COPD): Likelihood of Approval

Share this article GlobalData tracks drug-specific phase transition and likelihood of approval scores, in addition to indication benchmarks based off 18 years of historical drug

April 18, 2024

Plant-based diets regulate gestational weight gain in early pregnancy

The study in the European Journal of Clinical Nutrition found that Iranian pregnant women adhering to plant-based diets had a lower risk of inadequate gestational

November 15, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.